ReviewInternational journal of dermatology2020

Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibration.

Feras M Ghazawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.